-
Fierce Pharma Asia—Enhertu's first-line win; Akeso bispecific's positive readout; Regeneron, Fujifilm's $3B deal
25 Apr 2025 14:54 GMT
… with chemotherapy in first-line lung cancer. Fujifilm Diosynth Biotechnologies signed a … the standard combination of Perjeta, Herceptin and chemotherapy. The two companies … -line squamous non-small cell lung cancer on progression-free survival. This …
-
Proposal To Fund Medicines For Lung Cancer, Breast Cancer And Respiratory Conditions
13 Sep 2024 00:42 GMT
… of advanced non-small-cell lung
cancer:
as a first treatment option …
since the emergence of trastuzumab (Herceptin) 20 years
ago."
Chair … .
Proposal
to fund treatments for lung cancer, breast cancer and
respiratory
conditions …
-
Enhertu Combo Improves Progression in HER2+ Metastatic Breast Cancer
21 Apr 2025 20:31 GMT
… survival compared with taxane, Herceptin (trastuzumab) and Perjeta … plus Perjeta versus taxane, Herceptin and Perjeta.
Additionally, … Enhertu monotherapy versus taxane, Herceptin and Perjeta ,remains … mutant non-small cell lung cancer, HER2-positive gastric …
-
[Latest] Global Lung Tumor Market Size/Share Worth USD 46.3 Billion by 2033 at a 7.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
15 Apr 2024 16:30 GMT
… lung tumor diagnosis. This delay could result in the diagnosis of lung tumors … Related Reports: Lung Cancer Liquid Biopsy Market: Lung Cancer Liquid Biopsy … (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix), …
-
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung Cancer
22 Feb 2024 14:19 GMT
… lung cancer, precision oncology has achieved notable advances. Lung cancer … ; Genentech), trastuzumab (Herceptin; Genentech), T-DM1 … Lung Cancer: From Broad Treatment to Individualized Approaches
Lung cancer … Immunotherapy in lung cancer. Transl Lung Cancer Res. …
-
Companion Diagnostic Nets European IVDR Certification for Pembrolizumab Eligibility in Gastric/GEJ Adenocarcinoma
17 Apr 2025 18:47 GMT
… used in non–small cell lung cancer, esophageal squamous cell carcinoma, cervical … pembrolizumab in combination with trastuzumab (Herceptin), fluoropyrimidine- and platinum-containing chemotherapy …
-
Tucatinib and Trastuzumab Demonstrates Safety, Efficacy in HER2-Mutated Breast Cancer
17 Apr 2025 15:43 GMT
… (Tukysa; Array BioPharma) and trastuzumab (Herceptin; Genentech) demonstrated clinically meaningful antitumor … non-squamous non-small cell lung cancer.1,6
In the BC …
-
The Targeted Pulse: SC Pembrolizumab Combo Matches SOC in NSCLC and CAR T-cells Transform the Solid Tumor Space
13 Apr 2025 11:06 GMT
… metastatic non–small cell lung cancer (NSCLC). In this … design.
“In patients with lung cancer, the combination of chemotherapy … IV non–small cell lung cancer and no alterations,” Felip … of pembrolizumab plus trastuzumab (Herceptin) and chemotherapy for HER2 …
-
Lung Cancer Surgery Market Worth USD 7.8 billion by 2030, Trends Analysis, Growth Rate, Share, Size, Revenue, Opportunities, Challenges, Key Drivers, Instrument, Procedure, Volume Data, Forecasts 2023-2030 | Exclusive Report by Delvens
15 May 2023 14:35 GMT
… of diagnosing and treating lung cancer Therapies for lung cancer can be broadly categorised … ;CAS9, Others), Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade …
-
Boryung's licensed-in lung cancer drug wins approval in Korea
27 Sep 2022 04:43 GMT
… : lurbinectedin), a small cell lung cancer (SCLC) drug licensed-in … for Zepzelca, a small cell lung cancer (SCLC) drug.
Under … faster than non-small cell lung cancer (NSCLC). SCLC also … and Samfenet, a biosimilar referencing Herceptin, in December.
This year …
About
© 1995-2025